Investigation of the effects of radionuclides used in nuclear medicine on organ dose and effective dose DOI Creative Commons
Turan Şahmaran, Hasan İkbal Atılgan

Journal of Health Sciences and Medicine, Journal Year: 2025, Volume and Issue: 8(3), P. 389 - 394

Published: May 30, 2025

Aims: The aim of this study is to investigate the effects 68Ga, 18F, 89Sr, 13N, 133Xe and 131I radionuclide sources on organ doses effective at different distances. Methods: In study, radionuclides commonly used in nuclear medicine applications were defined VMC dose calculation software determine values varying Additionally, rates each obtained using Rad pro calculator online program. Results: For a 10 mCi dose, average rate measurements conducted Specifically, 13N 89Sr delivered highest certain organs, whereas ve resulted lower doses. 100 cm for determined be 2.72 µSv, 2.94 2.50 2.84 0.91 1.16 respectively. 150 1.56 1.49 1.30 1.46 0.14 0.58 As distance increased, radiation exposure levels decreased. Conclusion: decreased significantly with from source, demonstrating importance maintaining applying ALARA principles clinical settings. Furthermore, avoiding close proximity source utilizing appropriate shielding methods are crucial minimizing exposure.

Language: Английский

Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer? DOI Creative Commons
Tryambak Srivastava, Ruby Dhar, Subhradip Karmakar

et al.

Reproductive Biology and Endocrinology, Journal Year: 2025, Volume and Issue: 23(1)

Published: Jan. 20, 2025

Language: Английский

Citations

2

Current Advances in PARP1‐Targeted Theranostics DOI
Jie Tong,

Baosheng Chen,

Tommaso Volpi

et al.

Journal of Labelled Compounds and Radiopharmaceuticals, Journal Year: 2025, Volume and Issue: 68(1-2)

Published: Jan. 1, 2025

Poly (ADP-ribose) polymerase 1 (PARP1) plays critical roles in DNA repair, chromatin regulation, and cellular equilibrium, positioning it as a pivotal target for therapeutic interventions cancer central nervous system (CNS) disorders. PARP1 responds to oxidative stress damage through PARylation, influencing energy depletion, survival, inflammation, genomic regulation many biological scenarios. PARP inhibitors (PARPis) have demonstrated efficacy against cancers harboring defective homologous recombination repair pathways, notably those linked BRCA mutations. PARP1-targeted PET imaging enables patient stratification, treatment assessment, PARPi pharmacodynamic evaluation other pathophysiological conditions. Importantly, theranostics emerged both diagnostic applications multiple types of cancers, representing advancement personalized oncology. However, its application brain tumors is limited by the heterogeneous integrity blood barrier (BBB) blood-tumor barrier. Thus, development BBB-penetrant tracers remains an unmet need cancers. This review summarizes current landscape radiopharmaceuticals radioligands targeting PARP1, detailing their pharmacological characteristics potential clinical uses. Furthermore, this discusses that can cross BBB, underscoring neurooncology neurological

Language: Английский

Citations

1

Novel bio-carriers for radionuclide delivery in cancer radiotherapy DOI

Lishan Wang,

Qing‐Yu He,

Jianping Man

et al.

Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 533, P. 216557 - 216557

Published: Feb. 26, 2025

Language: Английский

Citations

1

RGB-D Camera-Based Human Head Motion Detection and Recognition System for Positron Emission Tomography Scanning DOI Open Access

Y. Shan,

Zonghao Lu, Zhe Sun

et al.

Electronics, Journal Year: 2025, Volume and Issue: 14(7), P. 1441 - 1441

Published: April 2, 2025

Positron emission tomography (PET) is one of the most advanced imaging diagnostic devices in medical field, playing a crucial role tumor diagnosis and treatment. However, patient motion during scanning can lead to artifacts, which affect accuracy. This study aims develop head monitoring system identify select images with excessive corresponding periods. The system, based on an RGB-D structured-light camera, implements facial feature point detection, 3D information acquisition, monitoring, along user interaction software. Through phantom experiments volunteer experiments, system’s performance was tested under various conditions, including stillness, pitch movement, yaw comprehensive movement. Experimental results show that translational error less than 2.5 mm, rotational 2.0°, it output within 10 s after PET scanning, meeting clinical accuracy requirements showing significant potential for application.

Language: Английский

Citations

0

Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear: Parte II DOI

Luis Sancho,

A. Roteta,

I. Torres

et al.

Revista Española de Medicina Nuclear e Imagen Molecular, Journal Year: 2025, Volume and Issue: unknown, P. 500128 - 500128

Published: April 1, 2025

Citations

0

Estimation of cancer risk induced by radiation exposure in nuclear medical Staff: Impact of hand-absorbed dose DOI

Hussein Al-Shareefi,

Hossein Rajabi

Journal of Radiation Research and Applied Sciences, Journal Year: 2025, Volume and Issue: 18(2), P. 101529 - 101529

Published: April 19, 2025

Language: Английский

Citations

0

Unlocking the power of affibody conjugated radioactive metallopharmaceuticals for targeted cancer diagnosis and therapy DOI
Dhanashree Murugan,

Harashkumar Vasanthakumari Thirumalaiswamy,

Vasanth Murugesan

et al.

Pharmacology & Therapeutics, Journal Year: 2025, Volume and Issue: unknown, P. 108863 - 108863

Published: April 1, 2025

Language: Английский

Citations

0

Assessment of basal TSPO expression and [18F]DPA-714 biodistribution in healthy mice and post-ischemic brain using PET imaging DOI
Brígida Gomes de Almeida Schirmer, Juliana de Oliveira Silva,

D. Navarro

et al.

Brazilian Journal of Radiation Sciences, Journal Year: 2025, Volume and Issue: 12(4A (Suppl.)), P. e2812 - e2812

Published: April 28, 2025

Positron emission tomography (PET) is an important tool in preclinical studies small animals, providing real-time insights into biochemical, metabolic, physiological, and functional processes. PET imaging also enables the assessment of biological responses biodistribution novel radiolabeled compounds within a single animal, minimizing need for larger animal groups. In particular, with [18F]DPA-714, Translocator Protein (TSPO) ligand, has shown high predictive prognostic value diseases associated neuroinflammation correlates well outcomes. this study, basal expression TSPO was investigated vivo C57BL/6 mice proposed as method to track new molecules. Male aged 6–9 weeks weighing 20–30 g were divided healthy ischemic The group subjected transient global cerebral ischemia induced by 25 min bilateral common carotid artery occlusion (BCCAO) followed reperfusion. Baseline [18F]DPA-714 performed static whole-body scans at 0-20, 20-40, 40-60, 60-80 post-injection intervals. After ischemia, used examine uptake [18F]DPA-714. results confirm that effective, non-invasive technique studies. Analysis SUVmean, SUVmax, SUVpeak metrics showed increased sensitivity brain following highlighting its importance models. Furthermore, baseline observed multiple organs, reflecting metabolic clearance pathways. comparable muscle underscores potential reliable marker studying TSPO-related inflammatory

Language: Английский

Citations

0

A novel 68Ga-labeled cyclic peptide: A potential radiotracer for PET imaging of CD36-positive cancers DOI
Bo Zhou, Y. Wang, Changhui Diao

et al.

Bioorganic Chemistry, Journal Year: 2025, Volume and Issue: 161, P. 108515 - 108515

Published: May 1, 2025

Language: Английский

Citations

0

Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear: Parte III DOI

I. Torres,

Rocío Ramos-Membrive,

M.L. Domínguez

et al.

Revista Española de Medicina Nuclear e Imagen Molecular, Journal Year: 2025, Volume and Issue: unknown, P. 500161 - 500161

Published: May 1, 2025

Citations

0